In our previous study, we evaluated six ESR1 mutations (K303R, S463P, Y537C, Y537N, Y537S, and D538G) in primary tumors, metastatic lesions and cfDNA of breast cancer patients [14]. This evidence concerns the gene ESR1 and breast cancer.